Ryan Birse

Director Clinical Diagnostics and Biopharma Services, Guardant Health

Role: Investigator

Sites: CDL-Toronto, CDL-Vancouver

Stream: Cancer

Ryan Birse PhD is currently the Director of Clinical Diagnostics and Biopharma Services at Guardant Health, Inc., a diagnostics company focused on building tools to improve the care of cancer patients. He earned his PhD degree in Neurobiology from Stockholm University, where he worked to elucidate the genetic mechanisms of neuropeptides regulation of metabolism. Prior to Guardant Health, he worked at Illumina as Director of Clinical Diagnostics and CDx development, and as a Medical Science Liaison with; Amgen (Hematology), Boston Scientific (Liver Cancer), Agena Bioscience (Lung, Colorectal, Melanoma), and a Staff Scientist with the Sanford, Burnham, Prebys Medical Research Institute where he worked on the Genetic and Epigenetic effects of gestational high fat diet on parental and transgenerational Cardiomyocyte function.